Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy.

BACKGROUND Patients with hypertension and left ventricular hypertrophy (LVH) are prone to develop heart failure. We tested the hypothesis that compensatory LVH is associated with normalization of myocardial oxygen consumption and that this occurs at the expense of a decrease in the ratio between cardiac work and oxygen consumption (efficiency). METHODS AND RESULTS Nine hypertensive men with LVH (LVH+) (age 42+/-2 years), left ventricular mass index (LVMI) 161+/-8 g/m(2), blood pressure (BP) 145+/-16/88+/-10 mm Hg (mean+/-SD); 8 hypertensive men without LVH (LVH-) (age 39+/-5 years, LVMI 107+/-15 g/m(2), BP 140+/-15/90+/-11 mm Hg); and 10 normotensive men (CONT) were studied. Myocardial blood flow, oxygen consumption, and glucose uptake were measured during euglycemic hyperinsulinemia using PET techniques. LV dimensions, volumes, and workload were determined by echocardiography, and efficiency was calculated. Myocardial workload (2.5+/-0.8 versus 3.0+/-0.6 versus 2. 3+/-0.5 mm Hg. mL. min(-1). g(-1) for CONT versus LVH- versus LVH+; P<0.05, LVH- versus LVH+), myocardial blood flow (0.84+/-0.16 versus 1.06+/-0.22 versus 0.81+/-0.09 mL. g(-1). min, respectively; P<0.05, LVH- versus other groups) and oxygen consumption (0.09+/-0.02 versus 0.14+/-0.03 versus 0.11+/-0.01 ml. g(-1). min(-1), respectively; P<0. 05, LVH- versus other groups) were increased in the LVH- group. Myocardial efficiency was reduced in the LVH+ group (18.1+/-4.1% versus 15.1+/-2.3% versus 13.5+/-1.9%, respectively; P<0.05, LVH+ versus CONT). CONCLUSIONS Myocardial oxygen consumption per unit weight is increased in hypertensive patients without LVH but is normal in those with LVH. The normalization of oxygen consumption via hypertrophy occurs at the expense of efficiency, which may predispose hypertensive patients with LVH to heart failure.

[1]  X. Xu,et al.  ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. , 1997, Circulation.

[2]  K. Frayn,et al.  Calculation of substrate oxidation rates in vivo from gaseous exchange. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[3]  C. Ng,et al.  Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  D. Levy,et al.  Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. , 1987, The American journal of cardiology.

[5]  G. Buzzigoli,et al.  Coronary hemodynamics and myocardial metabolism during and after pacing stress in normal humans. , 1989, The American journal of physiology.

[6]  B. Strauer,et al.  Coronary haemodynamics in hypertensive heart disease. , 1992, European heart journal.

[7]  A. Jula,et al.  Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. , 1995, The Journal of clinical investigation.

[8]  B. Strauer,et al.  Coronary microangiopathy and cardiac hypertrophy. , 1990, European heart journal.

[9]  B. Strauer,et al.  Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. , 1993, Circulation.

[10]  F Shishido,et al.  Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. , 1988, Circulation.

[11]  M. Swindle,et al.  Premorbid determinants of left ventricular dysfunction in a novel model of gradually induced pressure overload in the adult canine. , 1997, Circulation.

[12]  B. Strauer,et al.  Myocardial oxygen consumption in chronic heart disease: role of wall stress, hypertrophy and coronary reserve. , 1979, The American journal of cardiology.

[13]  V. Oikonen,et al.  Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  M. Schwaiger,et al.  Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. , 1993, Journal of the American College of Cardiology.

[15]  D. Neglia,et al.  Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension. , 1997, Circulation.

[16]  E. J. Battersby,et al.  Effect of pressure development on oxygen consumption by isolated rat heart. , 1967, The American journal of physiology.

[17]  R. Matsuoka,et al.  Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. , 1987, The Journal of clinical investigation.

[18]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.

[19]  M. Hennersdorf,et al.  The Heart in Hypertension , 1981, International Boehringer Mannheim Symposia.

[20]  P. Anversa,et al.  Left ventricular failure induced by long-term hypertension in rats. , 1990, Circulation research.

[21]  B. Strauer Ventricular function and coronary hemodynamics in hypertensive heart disease. , 1979, The American journal of cardiology.

[22]  H. Vliegen,et al.  Changes in nonmyocyte tissue composition associated with pressure overload of hypertrophic human hearts. , 1989, Pathology, research and practice.

[23]  W Grossman,et al.  Wall stress and patterns of hypertrophy in the human left ventricle. , 1975, The Journal of clinical investigation.

[24]  A. Katz Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. , 1990, The New England journal of medicine.

[25]  B. Strauer,et al.  Coronary Hemodynamics in Hypertensive Heart Disease , 1987 .

[26]  D. Levy,et al.  The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. , 1987, Circulation.

[27]  B. Strauer Coronary hemodynamics in hypertensive heart disease. Basic concepts, clinical consequences, and experimental analysis of regression of hypertensive microangiopathy. , 1988, The American journal of medicine.

[28]  T Jones,et al.  Noninvasive quantification of regional myocardial metabolic rate for oxygen by use of 15O2 inhalation and positron emission tomography. Theory, error analysis, and application in humans. , 1996, Circulation.

[29]  J. Viikari,et al.  Early impairment of coronary flow reserve in young men with borderline hypertension. , 1998, Journal of the American College of Cardiology.